cabozantinib,atezolizumab
roche
['contact03', 'rcc,(-irccs),(-srcc),(-urcc)', 'atezo', 'cabozantinib']
#contact03 negative results although important study by : adding atezolizumab to cabozantinib did not improve outcomes for metastatic #rcc after progression on 1st line io with inc toxicity published in today #asco23 
GU Oncologist | 🇨🇦 GU & NOLA Heme/Onc Alumni | Interested in GU, Immuno Onc & Med Ed | @ASCO Featured Voice | @TwoOncDocs podcast